I used GATK 4 for variant calling in bacteria samples. For some samples and some variants, there is no call. How can I know this no call is because of low-quality or gene absence?
Unconfigured Ad
Collapse
X
-
I like breseq http://barricklab.org/twiki/bin/view...meResequencing because it shows the evidence for each variant call and highlights regions of no coverage as well.Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com
-
What is the output? A vcf file will typically give the genotype call and then report on read depth, allele depth, genotype probabilities and quality scores for the call, mapping, and sequences. Can you manually inspect the GATK output? You can also load the bam file into a genome viewer and inspect the region of interest.Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com
Comment
-
@SNPsaurus, yes the output is a gvcf file (almost same as vcf file), and it has all the information that you mentioned. Here, is an example of one locus in one sample with no call.
eg. NC_000913 4473651 . C <non_ref> . . . GT:AD: DP:GQ:PL 0:2,0:2:0:0,0
and after combining with other samples and genotyping it with GASTK4, it will change to this:
GT:AD: DP:GQ:PL .:0,0:0:.:0,0Last edited by Negin; 09-12-2019, 06:47 AM.
Comment
-
So this has 2 reads of the reference, but converts to a no call? Do other loci with only reads get called? There may be a firm threshold for needing >2 reads to support a call. GQ is 0, so that means alternative genotypes are equally likely. I'd say if other loci get called at 2 reads then you need to visualize the alignments to see what is going on.Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Comment